SCHEMBL6909692

SCHEMBL6909692

Cc1cc(-c2ccccc2)nc(OCCC2CNCCN2c2cccc3c2OCCO3)c1S(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
GAA P10253 4/20 0.40
ALDH1A1 P00352 3/20 0.40
NPSR1 Q6W5P4 4/20 0.39
LMNA P02545 4/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 1/20 0.39
GLA P06280 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ADRB1 P08588 1/20 0.34
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
HTR1A P08908 4/20 0.33
DRD2 P14416 4/20 0.33
HTR2A P28223 3/20 0.32
HTR7 P34969 3/20 0.32
HTR6 P50406 3/20 0.32
BRD4 O60885 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876356 0.80 HTR1A (0.47) HTR1ADRD2
SCHEMBL6909700 0.75 NPSR1 (0.35) KDM4EGAAALDH1A1NPSR1LMNA
SCHEMBL31052124 0.68 ADRB1 (0.54) ALDH1A1LMNAADRB1HTR1A
SCHEMBL31051783 0.68 ADRB1 (0.54) ALDH1A1LMNAADRB1HTR1A
SCHEMBL31052121 0.68 ADRB1 (0.57) ALDH1A1LMNAADRB1HTR1A
SCHEMBL31052061 0.66 ADRB1 (0.57) ALDH1A1LMNAADRB1HTR1A
SCHEMBL31052261 0.66 ADRB1 (0.60) ALDH1A1LMNAADRB1HTR1A
SCHEMBL31052043 0.64 ADRB1 (0.59) ALDH1A1LMNAADRB1HTR1A
SCHEMBL31051731 0.62 ADRB1 (0.59) ALDH1A1LMNAADRB1HTR1AHTR2A
SCHEMBL31051771 0.62 ADRB1 (0.59) ALDH1A1LMNAADRB1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2004-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use GRIN2C, GRIN2B, HTR1A KDM4E 3350/4885GAA 272/4885ALDH1A1 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.